Citation Impact
Citing Papers
A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein–Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer
2014
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
Effective Treatment of Metastatic Forms of Epstein-Barr Virus–Associated Nasopharyngeal Carcinoma with a Novel Adenovirus-Based Adoptive Immunotherapy
2012
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
2010 StandoutNobel
Jinx , an MCMV susceptibility phenotype caused by disruption of Unc13d : a mouse model of type 3 familial hemophagocytic lymphohistiocytosis
2007 StandoutNobel
Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice
2011 StandoutNobel
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
2011 Standout
Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein–Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients
2013
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis
1996 Standout
Nasopharyngeal carcinoma
2005 Standout
A phase II study evaluating the safety and efficacy of an adenovirus-ΔLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic nasopharyngeal carcinoma
2011
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
The history of cancer epigenetics
2004 Standout
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
2011 StandoutNature
Multi-input chemical control of protein dimerization for programming graded cellular responses
2019 StandoutNobel
Vaccine strategies against Epstein‐Barr virus‐associated diseases: lessons from studies on cytotoxic T‐cell‐mediated immune regulation
1999
Cytogenetics in acute leukemia
2003
Prognostic Impact of Acute Myeloid Leukemia Classification: Importance of Detection of Recurring Cytogenetic Abnormalities and Multilineage Dysplasia on Survival
2003
Natural killer cell dysfunction: A common pathway in systemic‐onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis?
2004
Juvenile idiopathic arthritis
2007 Standout
Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry
1998
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Nasopharyngeal carcinoma
2019 Standout
CD4 and CD8 T cell responses to tumour-associated Epstein–Barr virus antigens in nasopharyngeal carcinoma patients
2007
A Rapamycin-Activated Caspase 9-Based Suicide Gene
2018
Neutropenic enterocolitis
2006
Membrane vesicles as conveyors of immune responses
2009 Standout
Functions of natural killer cells
2008 Standout
C-C chemokine receptor type-4 transduction of T cells enhances interaction with dendritic cells, tumor infiltration and therapeutic efficacy of adoptive T cell transfer
2015
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Adoptive immunotherapy of cancer using CD4+ T cells
2009
Functional Inactivation of EBV-Specific T-Lymphocytes in Nasopharyngeal Carcinoma: Implications for Tumor Immunotherapy
2007
The Molecular Basis of Leukemia
2004
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
2008
Minimally Cultured Tumor-infiltrating Lymphocytes Display Optimal Characteristics for Adoptive Cell Therapy
2008
Experience With Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome at a Single Institution
2009
Biological aspects of Epstein–Barr virus (EBV)-infected lymphocytes in chronic active EBV infection and associated malignancies
2002
Nasopharyngeal carcinoma
2015 Standout
Adoptive Transfer of EBV-specific T Cells Results in Sustained Clinical Responses in Patients With Locoregional Nasopharyngeal Carcinoma
2010
Short Telomeres are Sufficient to Cause the Degenerative Defects Associated with Aging
2009 StandoutNobel
11q23 balanced chromosome aberrations in treatment‐related myelodysplastic syndromes and acute leukemia: Report from an International Workshop†
2002
Adoptive T-cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma
2013
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Characterization of fusion partner genes in 114 patients with de novo acute myeloid leukemia and MLL rearrangement
2005
Epstein–Barr virus: 40 years on
2004 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Juvenile Xanthogranulomas in the First Two Decades of Life: A Clinicopathologic Study of 174 Cases With Cutaneous and Extracutaneous Manifestations
2003 Standout
Hemophagocytic lymphohistiocytosis and primary immune deficiency disorders
2014
The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia
2001
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
2008
Cancer immunotherapy comes of age
2011 StandoutNature
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
2020 Standout
Regulation of immune responses by extracellular vesicles
2014 Standout
Childhood Leukemias
1995
The Management of Neoplastic Disorders of Haematopoeisis in Children with Down's Syndrome
2000
IgG4-related disease
2014 Standout
Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13‐4 polymorphisms
2008
Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders
2001
Down's syndrome
2003 Standout
Genetic Alterations during Colorectal-Tumor Development
1988 Standout
Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases
2008 StandoutNobel
Expansion of EBV latent membrane protein 2a specific cytotoxic T cells for the adoptive immunotherapy of EBV latency type 2 malignancies: influence of recombinant IL12 and IL15
2003
“Juvenile” Xanthogranuloma
2001
Alpharetroviral self-inactivating vectors produced by a superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytes
2016 StandoutNobel
Realistic Pathologic Classification of Acute Myeloid Leukemias
2001
The histiocytoses: The fall of the Tower of Babel
1999
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Update on juvenile xanthogranuloma: Unusual cutaneous and systemic variants
1999
Technology Insight: applications of emerging immunotherapeutic strategies for Epstein–Barr virus-associated malignancies
2005
Epstein–Barr Virus Infection
2000 Standout
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Extracellular vesicles: Exosomes, microvesicles, and friends
2013 Standout
Dendritic Cell and Histiocytic Neoplasms: Biology, Diagnosis, and Treatment
2014
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 StandoutScience
Cell Therapy of Stage IV Nasopharyngeal Carcinoma With Autologous Epstein-Barr Virus–Targeted Cytotoxic T Lymphocytes
2005
Genetic mechanisms of tumor-specific loss of 11p DNA sequences in Wilms tumor.
1987
mb-1: a new marker for B-lineage lymphoblastic leukemia
1993
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-γ-producing lymphocytes and IL-6- and TNF-α-producing macrophages
2004
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder
2004
Prognostic value of cytogenetic findings in adults with acute myeloid leukemia.
2000
Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine- Directed Therapies
2014
Cytokine Storm
2020 Standout
Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger
2008 StandoutNobel
Macrophage activation syndrome
2002
Frequent detection of BRAFV 600E mutations in histiocytic and dendritic cell neoplasms
2014
Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective
2015
Fibrohistiocytic Tumors and Related Neoplasms in Children and Adolescents
2012
Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma
2003
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Whole‐Exome Sequencing Reveals Overlap Between Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis and Familial Hemophagocytic Lymphohistiocytosis
2014
Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses
2008 StandoutNobel
Perforin is a critical physiologic regulator of T-cell activation
2011
Induction of Therapeutic T-Cell Responses to Subdominant Tumor-associated Viral Oncogene after Immunization with Replication-incompetent Polyepitope Adenovirus Vaccine
2004
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Blood diffusion and Th1-suppressive effects of galectin-9–containing exosomes released by Epstein-Barr virus–infected nasopharyngeal carcinoma cells
2008
Functional Reversion of Antigen-Specific CD8+ T Cells from Patients with Hodgkin Lymphoma following In Vitro Stimulation with Recombinant Polyepitope
2006
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study
2000
PULMONARY MANIFESTATIONS OF NONTUBERCULOUS MYCOBACTERIUM
1995
Prognostic Impact of Acute Myeloid Leukemia Classification
2003
Works of Mary V. Gresik being referenced
Contemporary classification of histiocytic disorders
1997
Typhlitis. An 18-year experience and postmortem review
1990
Expression of myeloid-associated and lymphoid-associated cell-surface antigens in acute myeloid leukemia of childhood: a Pediatric Oncology Group study.
1992
Clinical Protocol: Administration of Neomycin Resistance Gene-Marked EBV-Specific Cytotoxic T-Lymphocytes as Therapy for Patients Receiving a Bone Marrow Transplant for Relapsed EBV-Positive Hodgkin Disease.
2000
Administration of Neomycin Resistance Gene Marked EBV Specific Cytotoxic T-Lymphocytes to Patients with Relapsed EBV-Positive Hodgkin Disease. Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas
1998
The Perlman familial nephroblastomatosis syndrome
1986
Pneumonia in hairy-cell leukemia.
1981
Treatment of nasopharyngeal carcinoma with Epstein-Barr virus–specific T lymphocytes
2004
Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821.
1999